Results 21 to 30 of about 949,112 (257)

Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study

open access: yesHarm Reduction Journal, 2021
Background Pharmacists are among the most accessible healthcare providers in the United States and uniquely positioned to provide harm reduction services.
Rachel A. Parry   +5 more
doaj   +1 more source

Patterns and sociodemographic characteristics of substance abuse among hepatitis C virus-infected patients in Iraq: a cross-sectional study

open access: yesThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Background Substance use disorders are a widely recognized problem among hepatitis C-infected patients; moreover, substance abuse by intravenous injection is a common mode of transmission of the hepatitis C virus worldwide. The frequency of substance use
Noor Ali Hasan, Nesif Al-Hemiary
doaj   +1 more source

Confronting the opioid crisis with consumer health information: a look at East Tennessee

open access: yesJournal of the Medical Library Association, 2021
Background: Starting in the 1990s, health care providers began prescribing opioids to patients as pain relievers, believing they were safe. However, many patients became addicted to these pills.
Kelsey Leonard Grabeel, Jenny C. Moore
doaj   +1 more source

Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long‐chain fatty acid accumulation after myocardial ischemia–reperfusion in mice

open access: yesFEBS Open Bio, EarlyView.
In a murine model of myocardial ischemia and reperfusion (MI/R), the CD36 azapeptide ligand MPE‐298 reduces cardiac injury and transiently lowers left ventricular long‐chain fatty acids (LCFAs) accumulation 3 h after reperfusion, accompanied by a decrease of oxidative stress and inflammation‐associated genes' expression in the heart and adipose tissue.
Jade Gauvin   +12 more
wiley   +1 more source

Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA

open access: yesEmerging Infectious Diseases, 2018
The epidemic of illicit intravenous drug use (IVDU) in the United States has been accompanied by a surge in drug overdose deaths and infectious sequelae.
Nongnooch Poowanawittayakom   +5 more
doaj   +1 more source

Sociodemographic and clinical profile of drug treatment seekers attending the State Psychiatric Hospital and Drug De-addiction Center at Agartala, Tripura

open access: yesIndian Journal of Psychiatry, 2021
Background: Substance use disorders have become a widespread public health problem, especially in the northeastern states, and limited studies have been undertaken to reflect the picture of the same.
Udayan Majumder   +4 more
doaj   +1 more source

Substance abuse treatment, what do we know? [PDF]

open access: yes, 2005
Substance abuse, Alcohol misuse, Survey, Treatment evaluation, Effectiveness,
Machado, Matilde P., Matilde Machado
core   +1 more source

Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui   +10 more
wiley   +1 more source

Psychiatric and Medical Co-morbidities among the substance abusers presenting at Patna Medical college- A clinical study

open access: yesAsian Journal of Medical Sciences, 2021
Background: The link between hazardous types of illegal drug use and significant public health issues is a critical issue for national and international drug policy. There are several negative health effects connected with drug use, with the avoidance of
Vivek Pratap Singh   +2 more
doaj   +1 more source

Engineered Nanoplatforms Targeting Activated Hepatic Stellate Cells for Liver Fibrosis Therapy via TGF‐β Axis Inhibition and Ferroptosis Induction

open access: yesAdvanced Healthcare Materials, EarlyView.
FeS‐VA@lanifibranor (FVL), an activated hepatic stellate cell (aHSC)‐targeted nanoplatform comprising vitamin A‐functionalized two‐dimensional iron sulfide nanosheets and lanifibranor, is engineered for precision therapy of liver fibrosis. FVL suppresses the TGF‐β signaling pathway by inhibiting SMAD2/3 phosphorylation and induces ferroptosis in aHSCs,
Yinuo Yang   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy